SBC Medical Group Holdings Inc current report, 26 April 2023

SEC Form 8-K Summary

Registrant: Pono Capital Two, Inc. (proposed business combination partner of SBC Medical Group Holdings Incorporated)

Report date: April 26, 2023; the filing was signed April 28, 2023.

Business Context and Reporting Period

The filing reports an amendment to the January 31, 2023 Agreement and Plan of Merger between Pono Capital Two, Pono Two Merger Sub, SBC Medical Group Holdings Incorporated, Mehana Capital, LLC, and the seller representative. The transaction remains subject to customary closing conditions, including Pono stockholder approval and other conditions described in the merger documents.

Financial and Operating Metrics

This Form 8-K does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating performance metrics for Pono or SBC.

The filing states that SBC or its affiliate agreed to purchase $1.0 million of equity in the Sponsor. The filing does not provide a broader financing plan or updated financial statements.

Material Changes Versus Prior Disclosure

  • The Sponsor may direct Pono to issue all or a portion of the 1.2 million Sponsor Shares on an earlier or later date, at the Sponsor’s discretion, provided the issuance is not earlier than the merger closing. Previously, issuance was scheduled for the earlier of six months after closing or expiration of the Founder Shares Lock-up Period.
  • The deadline for SBC to complete disclosure schedules, Pono to complete due diligence, and the parties to agree on related merger agreement modifications was extended from April 28, 2023 to May 31, 2023.
  • SBC agreed to purchase, or cause an affiliate to purchase, $1.0 million of equity in the Sponsor under separate investment documents to be entered into by May 5, 2023.
  • If the investment documents are not executed by May 5, 2023, either party may terminate the merger agreement during the following two business days.
  • If SBC does not fund the investment by May 15, 2023, Pono may terminate the merger agreement during the following two business days.

Outlook, Risks, and Unusual Items

The filing contains no operating guidance. The proposed business combination may not close, may be delayed, or may be terminated. Key identified risks include failure to satisfy closing conditions or obtain stockholder approval, excessive redemptions, failure to meet Nasdaq listing standards, legal proceedings, disruption to SBC’s business, the need for additional capital, and uncertainty regarding SBC’s future financial performance, revenue, capital expenditures, liquidity, and market opportunities.

The $1.0 million Sponsor investment and the revised timing and discretion regarding Sponsor Share issuance are material transaction-related items. The filing also states that the Form 8-K is not itself an offer to sell securities or a solicitation of proxies, and that additional transaction information is expected in a future proxy statement and related SEC filings.

Important Facts for Investors to Verify

  • Whether the required investment documents were executed by May 5, 2023 and whether the $1.0 million investment was funded by May 15, 2023.
  • Whether Pono and SBC completed the required disclosure schedules, due diligence, and merger agreement modifications by May 31, 2023.
  • Whether Pono stockholders approved the transaction and whether all other closing conditions were satisfied.
  • The final number and timing of Sponsor Shares issued, and the resulting dilution to public stockholders.
  • Actual redemption levels, post-transaction capitalization, financing needs, and compliance with Nasdaq listing requirements.
  • The financial statements, risk factors, transaction valuation, and projections included in the subsequent proxy statement and other SEC filings.